Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective study

Background: Hypertrophic cardiomyopathy (HCM) is considered rare in dogs, and there is a lack of clinical data. Cardiac troponin I (cTnI) is a biomarker of cardiomyocyte damage and necrosis and can be used to diagnose cat and human HCM. Aim: We investigated whether the presence of cTnI in clinical...

Full description

Bibliographic Details
Main Authors: Takeki Ando, Takeshi Izawa, Hidetaka Nishida, Hideo Akiyoshi
Format: Article
Language:English
Published: Tripoli University 2023-06-01
Series:Open Veterinary Journal
Subjects:
Online Access:https://www.openveterinaryjournal.com/?mno=144798
_version_ 1827790883046555648
author Takeki Ando
Takeshi Izawa
Hidetaka Nishida
Hideo Akiyoshi
author_facet Takeki Ando
Takeshi Izawa
Hidetaka Nishida
Hideo Akiyoshi
author_sort Takeki Ando
collection DOAJ
description Background: Hypertrophic cardiomyopathy (HCM) is considered rare in dogs, and there is a lack of clinical data. Cardiac troponin I (cTnI) is a biomarker of cardiomyocyte damage and necrosis and can be used to diagnose cat and human HCM. Aim: We investigated whether the presence of cTnI in clinical data can be used in conjunction with echocardiography to diagnose canine HCM. Methods: This study comprised client-owned dogs with clinical evidence of concentric hypertrophy on echocardiographic images, serum total thyroxine levels of ≤5 µg/dL, systolic blood pressure of ≤180 mmHg, and absence of aortic stenosis. All cases were necropsied. Results: Cardiomyocyte hypertrophy (mean diameter, 18.3 ± 1.8 µm), myocardial fiber disarray (70%), interstitial fibrosis (80%), and small vessel disease (100%) were assessed. In dogs with HCM, the left ventricles were concentric, almost symmetrical, and hypertrophied above the aortic diameter. The end-diastolic interventricular septum normalized to body weight (IVSDN) was 0.788 (interquartile range [IQR], 0.7–0.92), which exceeded the normal range (5%–95%, IQR: 0.33–0.52). In total, 70% of the dogs with HCM had syncope and dispnea, and all dogs had high cardiac troponin I levels (median, 3.94 ng/mL), exceeding the upper limit of normal (0.11 ng/ml) and indicating cardiomyocyte damage. IVSDN and serum cTnI levels were correlated (p = 0.839, P = 0.01). Conclusion: Ventricular wall thickening and high serum cTnI levels can provide a presumptive diagnosis of HCM and prompt the initiation of treatment or additional diagnostic investigations. [Open Vet J 2023; 13(6.000): 742-752]
first_indexed 2024-03-11T17:38:02Z
format Article
id doaj.art-996e5a2834274f8f94cb7c422aeb05c7
institution Directory Open Access Journal
issn 2226-4485
language English
last_indexed 2024-03-11T17:38:02Z
publishDate 2023-06-01
publisher Tripoli University
record_format Article
series Open Veterinary Journal
spelling doaj.art-996e5a2834274f8f94cb7c422aeb05c72023-10-18T15:29:29ZengTripoli UniversityOpen Veterinary Journal2226-44852023-06-0113674275210.5455/OVJ.2023.v13.i6.9144798Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective studyTakeki Ando0Takeshi Izawa1Hidetaka Nishida2Hideo Akiyoshi3Laboratory of Veterinary Surgery, Graduate School of Osaka Metropolitan University, Osaka 598-8531, Japan Laboratory of Veterinary Graduate School of Osaka Metropolitan University, Osaka 598-8531, Japan Laboratory of Veterinary Surgery, Graduate School of Osaka Metropolitan University, Osaka 598-8531, Japan Laboratory of Veterinary Surgery, Graduate School of Osaka Metropolitan University, Osaka 598-8531, JapanBackground: Hypertrophic cardiomyopathy (HCM) is considered rare in dogs, and there is a lack of clinical data. Cardiac troponin I (cTnI) is a biomarker of cardiomyocyte damage and necrosis and can be used to diagnose cat and human HCM. Aim: We investigated whether the presence of cTnI in clinical data can be used in conjunction with echocardiography to diagnose canine HCM. Methods: This study comprised client-owned dogs with clinical evidence of concentric hypertrophy on echocardiographic images, serum total thyroxine levels of ≤5 µg/dL, systolic blood pressure of ≤180 mmHg, and absence of aortic stenosis. All cases were necropsied. Results: Cardiomyocyte hypertrophy (mean diameter, 18.3 ± 1.8 µm), myocardial fiber disarray (70%), interstitial fibrosis (80%), and small vessel disease (100%) were assessed. In dogs with HCM, the left ventricles were concentric, almost symmetrical, and hypertrophied above the aortic diameter. The end-diastolic interventricular septum normalized to body weight (IVSDN) was 0.788 (interquartile range [IQR], 0.7–0.92), which exceeded the normal range (5%–95%, IQR: 0.33–0.52). In total, 70% of the dogs with HCM had syncope and dispnea, and all dogs had high cardiac troponin I levels (median, 3.94 ng/mL), exceeding the upper limit of normal (0.11 ng/ml) and indicating cardiomyocyte damage. IVSDN and serum cTnI levels were correlated (p = 0.839, P = 0.01). Conclusion: Ventricular wall thickening and high serum cTnI levels can provide a presumptive diagnosis of HCM and prompt the initiation of treatment or additional diagnostic investigations. [Open Vet J 2023; 13(6.000): 742-752]https://www.openveterinaryjournal.com/?mno=144798biomarkercardiac troponin idogend-diastolic thickness of the interventricular septumhypertrophic cardiomyopathy
spellingShingle Takeki Ando
Takeshi Izawa
Hidetaka Nishida
Hideo Akiyoshi
Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective study
Open Veterinary Journal
biomarker
cardiac troponin i
dog
end-diastolic thickness of the interventricular septum
hypertrophic cardiomyopathy
title Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective study
title_full Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective study
title_fullStr Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective study
title_full_unstemmed Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective study
title_short Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective study
title_sort clinical findings using echocardiography and plasma cardiac troponin i and pathological findings in dogs with hypertrophic cardiomyopathy a retrospective study
topic biomarker
cardiac troponin i
dog
end-diastolic thickness of the interventricular septum
hypertrophic cardiomyopathy
url https://www.openveterinaryjournal.com/?mno=144798
work_keys_str_mv AT takekiando clinicalfindingsusingechocardiographyandplasmacardiactroponiniandpathologicalfindingsindogswithhypertrophiccardiomyopathyaretrospectivestudy
AT takeshiizawa clinicalfindingsusingechocardiographyandplasmacardiactroponiniandpathologicalfindingsindogswithhypertrophiccardiomyopathyaretrospectivestudy
AT hidetakanishida clinicalfindingsusingechocardiographyandplasmacardiactroponiniandpathologicalfindingsindogswithhypertrophiccardiomyopathyaretrospectivestudy
AT hideoakiyoshi clinicalfindingsusingechocardiographyandplasmacardiactroponiniandpathologicalfindingsindogswithhypertrophiccardiomyopathyaretrospectivestudy